Ledger.Open graph →
SEC Form D · Amendment · filed June 21, 2022

Telo Therapeutics, Inc

Offering
$10.2M
Sold
$4.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert G. Blazej · San Francisco, CADirectorRobert Bell · San Francisco, CAExec · DirectorJoseph Costello · San Francisco, CADirectorMichael D. Taylor · San Francisco, CADirectorEvan Dreifuss · Venice, CADirectorTaavi Davies · Grand Cayman, Cayman IslandsExec · DirectorNicholas C. Gaze · Grand Cayman, Cayman IslandsDirectorSchnitzel Capital, LLC · Venice, CADirectorDavid Till · Luxembourg, LuxembourgDirectorMaritz G. Theron · Luxembourg, LuxembourgDirectorChong K. Moua · Wayne, PADirectorFai Man Yiu · HONG KONG, IsraelExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗